NSE: ADVENZYMES | BSE: 540025

Mid-range Performer

Download real time

306.85 7.05 (2.35%)

46.26% Fall from 52W High

113.2K NSE+BSE Volume

NSE 13 Aug, 2025 11:14 AM (IST)

3,433.1

Market Cap

Below industry Median

1.0

Beta 1Year

Average volatility

Advanced Enzyme Technologies Ltd. share price target and research reports

Name: Latest research reports of Advanced Enzyme Technologies Ltd. authored by ICICI Direct and published by - Trendlyne research reports.
Item: Advanced Enzyme Technologies Ltd.
Rating: 5
Author: ICICI Direct

Latest analyst research reports with target prices and PDF download for ADVENZYMES, BSE:540025 Advanced Enzyme Technologies Ltd.

Search Inside the pdf :

Advanced Enzyme Technologies Ltd.

17 May 2024

306.85

2.35%

Advance Enzyme Techologies

Buy: Advanced Enzyme Technologi...

Recommendation Target

ICICI Direct

Advanced Enzyme Technologies Ltd. is trading below all available SMAs

Advanced Enzyme Technologies Ltd.

18 May 2023

306.85

2.35%

Advanced Enzyme Technologies

Hold: Advanced Enzyme Technologi...

Target

ICICI Direct

Advanced Enzyme Technologies Ltd. is trading below all available SMAs

Advanced Enzyme Technologies Ltd.

22 Nov 2022

306.85

2.35%

Advanced Enzyme Technologies

Hold: Advanced Enzyme Technologi...

Recommendation Target

ICICI Direct

Advanced Enzyme Technologies Ltd. is trading below all available SMAs

Advanced Enzyme Technologies Ltd.

08 Aug 2022

306.85

2.35%

Advanced Enzyme Technologies

Sell: Advanced Enzyme Technologi...

Recommendation Target

ICICI Direct

Institutional Investors have increased holdings from 20.09% to 31.90% in Jun 2025 qtr.

Advanced Enzyme Technologies Ltd.

24 May 2022

306.85

2.35%

Advanced Enzyme Technologies

Hold: Advanced Enzyme Technologi...

ICICI Direct

Advanced Enzyme Technologies Ltd. is trading below all available SMAs

Advanced Enzyme Technologies Ltd.

09 Feb 2022

306.85

2.35%

Advanced Enzyme Technologies

Buy: Advanced Enzyme Technologi...

Target

ICICI Securities Limited

It has seven manufacturing and six R&D facilities, which consist of three integrated fermentations, recovery & formulation facilities, one extraction and recovery facility and one satellite blending, mixing & formulation facility Q3FY22 Results: Margin pressure due to logistics challenge and high raw material cost continues to weigh on numbers....

Advanced Enzyme Technologies Ltd. is trading below all available SMAs

Advanced Enzyme Technologies Ltd.

08 Nov 2021

306.85

2.35%

Advanced Enzyme Technologies

Buy: Advanced Enzyme Technologi...

Target

ICICI Securities Limited

AET remains a marginal player in the global enzymes landscape that is estimated at ~US$10 billion and poised to grow at 6-7% CAGR as more applications across usage industries incorporate enzymatic technologies It has got proven capabilities and stable financials, thanks to a mix of organic and inorganic growth strategy employed by management Going ahead, AET plans to augment its R&D; capability that bodes well in the long run in its quest to improve scalability & foraying into complex enzymes...

Advanced Enzyme Technologies Ltd. is trading below all available SMAs

Advanced Enzyme Technologies Ltd.

12 Aug 2021, 12:00AM

306.85

2.35%

Advanced Enzyme Technologies

Buy: Advanced Enzyme Technologi...

ICICI Securities Limited

Target Price and Valuation: We value AET at | 480 i.e. 26x P/E on FY23E EPS. AET remains a marginal player in the global enzymes landscape that is estimated at ~US$10 billion and poised to grow at 6-7% CAGR as more...

Institutional Investors have increased holdings from 20.09% to 31.90% in Jun 2025 qtr.

Advanced Enzyme Technologies Ltd.

16 Feb 2021

306.85

2.35%

Advanced Enzyme Technologies

Buy: Advanced Enzyme Technologi...

Target

ICICI Securities Limited

Globally, growth of the enzymes market piggybacks on a diverse spectrum of customer base. This, together with limited number of meaningful players, has created a conducive business environment for existing players in the space. Note that enzymes as cost to percentage of sales is not material, yet its efficacy is very important to end product including constituency of the end product in terms of its taste, appearance, aroma and, thus, quality perception of products leading to significant supplier stickiness. With a revenue bandwidth of just | 440 crore (~US$60 million) AET remains a...

Advanced Enzyme Technologies Ltd. is trading below all available SMAs

Advanced Enzyme Technologies Ltd.

25 Nov 2020

306.85

2.35%

Advanced Enzyme Technologies

Buy: Advanced Enzyme Technologi...

ICICI Securities Limited

Globally, growth of the enzymes market piggybacks on a diverse spectrum of customer base. This, together with limited number of meaningful players, has created a conducive business environment for existing players in the space. Note that enzymes as cost to percentage of sales is not material, yet its efficacy is very important to end product including constituency of the end product in terms of its taste, appearance, aroma and, thus, quality perception of the products leading to significant supplier stickiness. With a revenue bandwidth of just | 440 crore (~US$60 million) AET remains a...

FII/FPI have increased holdings from 11.90% to 23.45% in Jun 2025 qtr.

Is Advanced Enzyme Technologies Ltd. worth buying?

344 Votes:

Buy 84.01%

Sell 11.05%

Hold 4.94%